Literature DB >> 32441669

A novel heterozygous mutation in the insulin receptor gene presenting with type A severe insulin resistance syndrome.

Arameh S Aghababaie1,2, Martha Ford-Adams3, Charles R Buchanan3, Ved B Arya3, Kevin Colclough4, Ritika R Kapoor3.   

Abstract

Background Inherited severe insulin resistance syndromes (SIRS) are rare and can be caused by mutations in the insulin receptor gene (INSR). Case presentation A 12-year-old Jamaican girl with a BMI of 24.4 kg/m2 presented with polyuria and polydipsia. A diagnosis of T1DM was made in view of hyperglycaemia (18 mmol/l), and elevated Hba1C (9.9%), and insulin therapy was initiated. Over the next 2 years, she developed hirsutism and acanthosis nigricans, and had minimal insulin requirements with frequent post-prandial hypoglycaemia. In view of this, and her strong family history suggestive of a dominantly inherited type of diabetes, the diagnosis was revisited. Targeted next-generation sequencing (NGS) of the patient's monogenic diabetes genes was performed. What is new? NGS revealed a novel heterozygous missense INSR variant, NM_000208.3:c.3471T>G, p.(His1157Gln), confirming a diagnosis of Type A SIRS. Conclusions Type A SIRS can be difficult to differentially diagnose due to the variable phenotype. Features of insulin resistance may be absent at initial presentation and may develop later during pubertal progress. Awareness of the clinical features and comprehensive genetic testing are essential to identify the condition.

Entities:  

Keywords:  acanthosis nigricans; hirsutism; insulin receptor gene; oligomenorrhoea; post-prandial hypoglycaemia; type A severe insulin resistance syndrome

Mesh:

Substances:

Year:  2020        PMID: 32441669     DOI: 10.1515/jpem-2019-0503

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  1 in total

1.  Syndromic Monogenic Diabetes Genes Should Be Tested in Patients With a Clinical Suspicion of Maturity-Onset Diabetes of the Young.

Authors:  Kevin Colclough; Sian Ellard; Andrew Hattersley; Kashyap Patel
Journal:  Diabetes       Date:  2022-03-01       Impact factor: 9.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.